XTAE
ILX
Market cap185mUSD
Jul 09, Last price
4,981.00ILS
1D
0.00%
1Q
-13.75%
Jan 2017
11,384.90%
Name
Ilex Medical Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ilex Medical Ltd. engages in medical diagnostics field. It operates through the following segments: Medical Laboratory Equipment and Diagnostics Materials, Medical Equipment, and Inhalation Devices. The Medical Laboratory Equipment and Diagnostics Materials segment deals with the marketing, distribution, and sale of laboratory medical equipment and diagnostics products, diagnostics systems, kits, and consumables for the examination of medical laboratories in hospitals. The Medical Equipment segment handles importation, marketing, and distribution of medical equipment and devices in Israel. The Inhalation Devices segment includes development, manufacture, and marketing of mobile inhalation devices. The company was founded by Moshe Ben Shaul in 1977 and is headquartered in Petach Tikva, Israel.
Valuation
Title ILS in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||